Metformin Use and the Outcome of Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib

BACKGROUND: The anticancer properties of metformin have been suggested in numerous experimental studies and several retrospective clinical studies show that its use is associated with improved outcome of patients with cancer. However, limited data are available for patients with metastatic renal cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiala, Ondřej, Ostašov, Pavel, Rozsypalová, Aneta, Hora, Milan, Šorejs, Ondřej, Šustr, Jan, Bendová, Barbora, Trávníček, Ivan, Filipovský, Jan, Fínek, Jindřich, Büchler, Tomáš
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153069/
https://www.ncbi.nlm.nih.gov/pubmed/34054309
http://dx.doi.org/10.2147/CMAR.S305321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153069/
https://www.ncbi.nlm.nih.gov/pubmed/34054309
http://dx.doi.org/10.2147/CMAR.S305321

Ejemplares similares